Mycobacterium avium-infectie bij HIV-geinfecteerde patienten: Epidemiologie, diagnose, profylaxe en behandeling

Translated title of the contribution: Mycobacterium avium infection in HIV-infected patients: Epidemiology, diagnosis, prophylaxis and treatment

M. M.E. Schneider*, P. Reiss, J. C.C. Borleffs, M. Rozenberg-Arska, I. M. Hoepelman

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

7 Citations (Scopus)

Abstract

- The prevalence of infection with Mycobacterium avium complex (MAC) has increased since the outbreak of the HIV pandemic. This complex comprises two organisms: M. avium (mostly) and M. intracellulare (rarely). The source of MAC infection is not known. - The principal risk factors for disseminated MAC infection in a patient with HIV infection are a low CD 4 count and a previous opportunistic infection. - The symptoms of disseminated MAC infection resemble those of HIV wasting: A positive culture of normally sterile tissue confirms a MAC infection. - There is reserve with regard to routine prophylaxis in HIV-infected persons because of the possible development of resistance, interaction with other drugs used in AIDS, toxicity and possible absorption disorders which might cause prophylaxis to fail. - For the treatment of disseminated MAC infection, a combination of at least two medicaments (macrolides and ethambutol) is recommended.

Translated title of the contributionMycobacterium avium infection in HIV-infected patients: Epidemiology, diagnosis, prophylaxis and treatment
Original languageDutch
Pages (from-to)80-83
Number of pages4
JournalNederlands Tijdschrift voor Geneeskunde
Volume141
Issue number2
Publication statusPublished - 4 Feb 1997

Fingerprint

Dive into the research topics of 'Mycobacterium avium infection in HIV-infected patients: Epidemiology, diagnosis, prophylaxis and treatment'. Together they form a unique fingerprint.

Cite this